Dr. Fogel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
30795 23 Mile Rd
Suite 206
Chesterfield, MI 48047Phone+1 586-598-5731Fax+1 586-948-1530- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 1977 - 1979
- University of California (San Francisco)Residency, Internal Medicine, 1977 - 1978
- McGill University Faculty of MedicineClass of 1974
Certifications & Licensure
- CA State Medical License 1976 - Present
- MI State Medical License 1990 - 2027
- IN State Medical License 1984 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (AGAF) American Gastroenterological Association, 2006
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsLong-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension.Evan S. Dellon, Margaret H. Collins, David A. Katzka, Vincent A. Mukkada, Gary W. Falk, Robin Morey, Bridgett Goodwin, Jessica D. Eisner, Lan Lan, Nirav K. Desai, Jame...> ;Clinical Gastroenterology and Hepatology. 2021 Jun 26
- 5 citationsPlecanatide Is Effective and Safe in the Treatment for Chronic Idiopathic Constipation: Results of a Phase II TrialCharles F. Barish, Spencer D. Dorn, Ronald Fogel, Reema Patel, Jonathan Rosenberg> ;Digestive Diseases and Sciences. 2021 Feb 1
- 36 citationsEffects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisSilvio Danese, Markus F. Neurath, Adam Kopon, Salam F. Zakko, Timothy C. Simmons, Ronald Fogel, Corey A. Siegel, Remo Panaccione, Xiaojiang Zhan, Keith Usiskin, Denesh...> ;Clinical Gastroenterology and Hepatology. 2020 Oct 1
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: